The effectiveness of i.v. cefuroxime prophylaxis of surgical site infection after elective inguinal hernia repair with mesh: A retrospective observational study Yeye ZhuoQian ZhangDe Cai Clinical Trial 10 May 2016 Pages: 1033 - 1039
First in man study of EP217609, a new long-acting, neutralisable parenteral antithrombotic with a dual mechanism of action Pierre GueretS. CombeE. Neuhart Clinical Trial 03 June 2016 Pages: 1041 - 1050
Comparative efficacy of nonhormonal drugs on menopausal hot flashes Lujin LiLing XuQingshan Zheng Pharmacodynamics 24 July 2016 Pages: 1051 - 1058
Influence of ACE gene on differential response to sertraline versus fluoxetine in patients with major depression: a randomized controlled trial Ehsan BahramaliNegar FirouzabadiRoja Asadpour Pharmacogenetics 05 June 2016 Pages: 1059 - 1064
Effect of renal function on the pharmacokinetics of LCZ696 (sacubitril/valsartan), an angiotensin receptor neprilysin inhibitor Surya P. AyalasomayajulaThomas H. LangenickelGangadhar Sunkara Pharmacokinetics and Disposition 26 May 2016 Pages: 1065 - 1073
Hair analysis for detection of triptans occasionally used or overused by migraine patients—a pilot study Anna FerrariCarlo BaraldiEnrico Silingardi Pharmacokinetics and Disposition Open access 31 May 2016 Pages: 1075 - 1081
Hematological toxicity of carboplatin for gynecological cancer according to body mass index Fernando GutierrezGuillermo Antonio Gonzalez-de-la-FuenteNorberto Batista Pharmacokinetics and Disposition 10 June 2016 Pages: 1083 - 1089
Pharmacokinetic patterns of risperidone-associated adverse drug reactions Georgios SchoretsanitisBenedikt StegmannMichael Paulzen Pharmacokinetics and Disposition 04 July 2016 Pages: 1091 - 1098
Impact of age, gender and CYP2C9/2C19 genotypes on dose-adjusted steady-state serum concentrations of valproic acid—a large-scale study based on naturalistic therapeutic drug monitoring data R. L. SmithT. HaslemoE. Molden Pharmacokinetics and Disposition 29 June 2016 Pages: 1099 - 1104
A methodological comparison of two European primary care databases and replication in a US claims database: inhaled long-acting beta-2-agonists and the risk of acute myocardial infarction A. AfonsoS. SchmiedlM. Rottenkolber Pharmacoepidemiology and Prescription 24 May 2016 Pages: 1105 - 1116
Polypharmacy and medication regimen complexity as factors associated with staff informant rated quality of life in residents of aged care facilities: a cross-sectional study Samanta LalicKris M. JamsenJ. Simon Bell Pharmacoepidemiology and Prescription 02 June 2016 Pages: 1117 - 1124
Clinical trials with direct oral anticoagulants for stroke prevention in atrial fibrillation: how representative are they for real life patients? S. DesmaeleS. SteurbautA. G. Dupont Pharmacoepidemiology and Prescription 07 June 2016 Pages: 1125 - 1134
Development of a quality instrument for assessing the spontaneous reports of ADR/ADE using Delphi method in China Lixun ChenLing JiangWei Wei Pharmacoepidemiology and Prescription 16 June 2016 Pages: 1135 - 1142
Drug-related hospital admissions among old people with dementia Maria GustafssonMaria SjölanderHugo Lövheim Pharmacoepidemiology and Prescription 05 July 2016 Pages: 1143 - 1153
Deferasirox AUC efficacy cutoff and role of pharmacogenetics S. AllegraJ. CusatoA. D’Avolio Letter to the Editor 18 May 2016 Pages: 1155 - 1157
Carriers of genetic variants in the HNF1A gene are more common among dead opioid addicts than among living addicts Anh NguyenTore B. StageKim Brøsen Letter to the Editor 30 May 2016 Pages: 1159 - 1160
